Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 4
2002 3
2003 2
2004 2
2006 3
2007 2
2008 1
2009 3
2010 3
2011 4
2012 7
2013 6
2014 2
2015 6
2016 4
2017 3
2018 1
2019 7
2020 7
2021 2
2022 6
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells.
Limagne E, Nuttin L, Thibaudin M, Jacquin E, Aucagne R, Bon M, Revy S, Barnestein R, Ballot E, Truntzer C, Derangère V, Fumet JD, Latour C, Rébé C, Bellaye PS, Kaderbhaï CG, Spill A, Collin B, Callanan MB, Lagrange A, Favier L, Coudert B, Arnould L, Ladoire S, Routy B, Joubert P, Ghiringhelli F. Limagne E, et al. Among authors: rebe c. Cancer Cell. 2022 Feb 14;40(2):136-152.e12. doi: 10.1016/j.ccell.2021.12.009. Epub 2022 Jan 19. Cancer Cell. 2022. PMID: 35051357 Free article.
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses.
Bruchard M, Geindreau M, Perrichet A, Truntzer C, Ballot E, Boidot R, Racoeur C, Barsac E, Chalmin F, Hibos C, Baranek T, Paget C, Ryffel B, Rébé C, Paul C, Végran F, Ghiringhelli F. Bruchard M, et al. Among authors: rebe c. Nat Immunol. 2022 Feb;23(2):262-274. doi: 10.1038/s41590-021-01120-y. Epub 2022 Jan 31. Nat Immunol. 2022. PMID: 35102345
Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy.
Niogret J, Berger H, Rebe C, Mary R, Ballot E, Truntzer C, Thibaudin M, Derangère V, Hibos C, Hampe L, Rageot D, Accogli T, Joubert P, Routy B, Harker J, Vegran F, Ghiringhelli F, Chalmin F. Niogret J, et al. Among authors: rebe c. J Immunother Cancer. 2021 Jun;9(6):e002157. doi: 10.1136/jitc-2020-002157. J Immunother Cancer. 2021. PMID: 34103351 Free PMC article.
Interleukin-1β and Cancer.
Rébé C, Ghiringhelli F. Rébé C, et al. Cancers (Basel). 2020 Jul 4;12(7):1791. doi: 10.3390/cancers12071791. Cancers (Basel). 2020. PMID: 32635472 Free PMC article. Review.
Editorial: Inflammasomes: Cornerstone of Immunity.
Rébé C, Ghiringhelli F, Sharma D. Rébé C, et al. Front Cell Dev Biol. 2022 Apr 14;10:888378. doi: 10.3389/fcell.2022.888378. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35493108 Free PMC article. No abstract available.
Heat Shock Proteins and Inflammasomes.
Martine P, Rébé C. Martine P, et al. Among authors: rebe c. Int J Mol Sci. 2019 Sep 12;20(18):4508. doi: 10.3390/ijms20184508. Int J Mol Sci. 2019. PMID: 31547225 Free PMC article. Review.
72 results